From: Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma
ID
Sex
Age
Disease
Stage
PTV volume (cc)
Prescription dose (Gy)
1
Male
62
HCC
III
483
55.0
2
54
I
60
66.0
3
59
421
52.5
4
Female
49
IV
2112
60.0
5
42
214
72.0